• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYHZ2100057 交联玻璃酸钠注射液 Injection Chemical Drugs License Renew 2021-03-25 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd Certificate Issued 2021-10-19 view
JYHZ2100058 交联玻璃酸钠注射液 Injection Chemical Drugs License Renew 2021-03-25 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd Certificate Issued 2021-10-28 view
JYSB2100059 兔抗人胸腺细胞免疫球蛋白 Rabbit Anti-human Thymocyte Immunoglobulin Lyophilized Biological Products Supplementary Application 2021-02-24 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd In Review 2022-01-27 view
JYSB2100060 兔抗人胸腺细胞免疫球蛋白 Rabbit Anti-human Thymocyte Immunoglobulin Lyophilized Biological Products Supplementary Application 2021-02-24 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd In Review 2021-02-23 view
JYSB2100052 甘精胰岛素注射液 insulin glargine Injection Biological Products Supplementary Application 2021-02-23 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd In Review 2021-02-22 view
JXHB2100016 SAR442168 tolebrutinib Active ingredient Chemical Drugs(1) Supplementary Application 2021-01-28 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd In Review 2021-01-27 view
JXHS2100012 注射用奥沙利铂 oxaliplatin Lyophilized Chemical Drugs(2.4) Import Drug Application 2021-01-28 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd Certificate Issued 2021-11-02 view
JXHB2100018 SAR442168 tolebrutinib Active ingredient Chemical Drugs(1) Supplementary Application 2021-01-28 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd In Review 2021-01-27 view
JXHB2100017 SAR442168 tolebrutinib Active ingredient Chemical Drugs(1) Supplementary Application 2021-01-28 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd In Review 2021-01-27 view
JYSB2100023 甘精胰岛素注射液 insulin glargine Injection Biological Products Supplementary Application 2021-01-19 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd In Review 2021-01-18 view
JYSB2100022 甘精胰岛素注射液 insulin glargine Injection Biological Products Supplementary Application 2021-01-19 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd In Review 2021-01-18 view
JYHB2100012 硫酸羟氯喹片 hydroxychloroquine sulfate Tablet Chemical Drugs Supplementary Application 2021-01-07 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd Filed 2021-01-19 view
JYSB2000683 度普利尤单抗注射液 dupilumab Injection Biological Products(3.1) Supplementary Application 2021-01-01 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd Certificate Issued 2021-09-22 view
JYSB2000645 注射用拉罗尼酶浓溶液 laronidase Injection Biological Products Supplementary Application 2020-12-21 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd Certificate Issued 2021-12-23 view
JYHB2002588 利鲁唑片 riluzole Tablet Chemical Drugs Supplementary Application 2020-12-16 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd Filed 2020-12-25 view
JXSL2000230 BIVV020注射液 riliprubart Injection Biological Products(1) Import Drug Application 2020-12-16 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd In Review 2020-12-15 view
JYSB2000624 甘精胰岛素注射液 insulin glargine Injection Biological Products Supplementary Application 2020-12-14 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd Filed 2020-12-25 view
JYHB2002571 硫酸羟氯喹片 hydroxychloroquine sulfate Tablet Chemical Drugs Supplementary Application 2020-12-14 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd Certificate Issued 2021-03-17 view
JYSB2000608 甘精胰岛素注射液 insulin glargine Injection Biological Products Supplementary Application 2020-12-10 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd Certificate Issued 2021-11-16 view
JYSB2000607 甘精胰岛素注射液 insulin glargine Injection Biological Products Supplementary Application 2020-12-10 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd Certificate Issued 2021-10-21 view